Santen Pharmaceutical Co., Ltd. (SNPHF)
OTCMKTS · Delayed Price · Currency is USD
9.51
-0.60 (-5.91%)
At close: Nov 25, 2025

Santen Pharmaceutical Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
3,6043,2323,6973,1924,0435,505
Market Cap Growth
6.91%-12.57%15.82%-21.04%-26.56%-20.18%
Enterprise Value
3,1962,7073,1502,7273,4795,022
Last Close Price
9.5110.299.148.3911.1113.54
PE Ratio
18.4713.3521.00-18.0489.19
PS Ratio
1.961.611.851.521.842.44
PB Ratio
2.001.701.831.451.461.98
P/TBV Ratio
2.742.302.522.152.373.13
P/FCF Ratio
15.908.928.8321.3617.1117.56
P/OCF Ratio
13.647.957.7011.4210.6615.69
EV/Sales Ratio
1.701.351.581.301.592.23
EV/EBITDA Ratio
8.196.126.776.907.987.90
EV/EBIT Ratio
11.778.399.1310.2711.7810.38
EV/FCF Ratio
14.107.477.5218.2414.7216.02
Debt / Equity Ratio
-0.120.110.120.100.03
Debt / EBITDA Ratio
-0.520.490.690.620.14
Debt / FCF Ratio
-0.630.551.821.150.29
Net Debt / Equity Ratio
-0.22-0.21-0.20-0.07-0.15-0.17
Net Debt / EBITDA Ratio
-1.02-0.89-0.85-0.41-0.95-0.75
Net Debt / FCF Ratio
-1.73-1.08-0.95-1.09-1.74-1.52
Asset Turnover
0.720.710.710.630.620.62
Inventory Turnover
2.262.722.992.952.792.56
Quick Ratio
1.731.902.001.851.912.02
Current Ratio
2.682.582.552.382.392.63
Return on Equity (ROE)
10.79%12.14%8.92%-4.75%8.45%2.18%
Return on Assets (ROA)
6.46%7.14%7.61%5.01%5.20%8.25%
Return on Invested Capital (ROIC)
14.88%15.46%18.05%12.64%10.12%11.99%
Return on Capital Employed (ROCE)
13.00%15.00%15.20%10.60%9.90%16.50%
Earnings Yield
5.42%7.49%4.76%-3.52%5.54%1.12%
FCF Yield
6.29%11.21%11.33%4.68%5.85%5.70%
Dividend Yield
2.63%2.34%2.39%2.87%2.37%1.87%
Payout Ratio
41.30%33.40%44.59%-44.07%163.81%
Buyback Yield / Dilution
6.20%5.01%4.98%3.26%-0.02%-0.03%
Total Shareholder Return
8.83%7.35%7.36%6.13%2.36%1.84%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.